Thank you for your interest in opening an account with ELISA/ACT Biotechnologies
Today, at least one out of every six Americans, or 40 million people in the United States, suffer from one or more of the autoimmune and immune dysfunction diseases. In response, chronically ill Americans spend over $300 billion per year directly for autoimmune syndrome treatments that often do not reduce their suffering or improve their health. That’s why Russell M. Jaffe, MD, Ph.D., CCN, NACB developed the patented LRA (LRA by ELISA/ACT™) tests and treatment plan in 1984, enabling thousands of physicians to quickly and precisely determine the hidden causes of many chronic conditions and help their patients find sustained relief. By looking directly at lymphocytes the LRA detects all 3 types of delayed food and chemical hypersensitivities to more than 500 items.